Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Feb 01, 2002	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0000950172-02-000172.pdf
Jan 24, 2002	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0000950123-02-000616.pdf
Jan 23, 2002	S-3/A	Pre-effective amendment to an S-3 filing	View HTML 0000950123-02-000590.pdf
Jan 22, 2002	S-3/A	Pre-effective amendment to an S-3 filing	View HTML 0000950123-02-000546.pdf
Dec 21, 2001	S-3/A	Pre-effective amendment to an S-3 filing	View HTML 0000950123-01-509508.pdf
Dec 04, 2001	S-3	Simplified registration form	View HTML 0000950123-01-508977.pdf
Dec 04, 2001	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000891836-01-500378.pdf 0000891836-01-500378.xls
Nov 28, 2001	SC 13D/A	An amendment to a SC 13D filing	View HTML 0000895345-01-500668.pdf
Nov 21, 2001	DEFS14A	A definitive proxy statement giving notice regarding a special meeting	View HTML 0000950123-01-508707.pdf
Nov 13, 2001	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0000950123-01-508241.pdf 0000950123-01-508241.xls

Data provided by Kaleidoscope.

Investors & Media